Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
Conditions:   Parkinson Disease;   Dyskinesia, Medication-Induced Interventions:   Drug: CPL500036 - low dose;   Drug: CPL500036 - high dose;   Drug: Placebo Sponsors:   Celon Pharma SA;   National Center for Research and Development, Poland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2022 Category: Research Source Type: clinical trials

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
Condition:   Primary Ciliary Dyskinesia Intervention:   Sponsor:   Arkansas Children's Hospital Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials